Exodus Point Capital Management, LP Catalent, Inc. Transaction History

Exodus Point Capital Management, LP

$16.4 Billion
Q3 2024

A detailed history of Exodus Point Capital Management, LP transactions in Catalent, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 5,800 shares of CTLT stock, worth $368,184. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,800

Previous 103,547 94.4%

Holding current value

$368,184

Previous $5.82 Million 93.97%

% of portfolio

0.0%

Previous 0.04%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$56.16 - $60.96 $5.41 Million - $5.88 Million	96,418 Added 93.12%	199,965 $12.1 Million
Q2 2024 Aug 13, 2024	BUY	$53.58 - $57.02 $3.95 Million - $4.21 Million	73,755 Added 247.57%	103,547 $5.82 Million
Q1 2024 May 14, 2024	BUY	$42.56 - $59.82 $618,864 - $869,842	14,541 Added 95.34%	29,792 $1.68 Million
Q3 2023 Nov 09, 2023	BUY	$44.2 - $50.2 $674,094 - $765,600	15,251 New	15,251 $694,000
Q1 2023 May 11, 2023	BUY	$45.44 - $74.26 $78,429 - $128,172	1,726 Added 37.14%	6,373 $419,000
Q4 2022 Feb 13, 2023	SELL	$41.39 - $81.0 $2.46 Million - $4.81 Million	-59,322 Reduced 92.74%	4,647 $209,000
Q3 2022 Nov 10, 2022	BUY	$72.36 - $113.1 $4.63 Million - $7.23 Million	63,969 New	63,969 $4.63 Million
Q1 2022 May 13, 2022	SELL	$94.19 - $124.49 $1.47 Million - $1.95 Million	-15,649 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$119.57 - $139.07 $1.87 Million - $2.18 Million	15,649 New	15,649 $2 Million
Q3 2021 Nov 15, 2021	SELL	$109.17 - $142.35 $403,055 - $525,556	-3,692 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$100.34 - $115.69 $721,444 - $831,811	-7,190 Reduced 66.07%	3,692 $399,000
Q1 2021 May 17, 2021	BUY	$101.51 - $125.27 $1.1 Million - $1.36 Million	10,882 New	10,882 $1.15 Million
Q2 2020 Aug 14, 2020	SELL	$48.02 - $79.04 $475,301 - $782,337	-9,898 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$36.95 - $62.95 $365,731 - $623,079	9,898 New	9,898 $514,000
Q4 2019 Feb 14, 2020	SELL	$47.06 - $56.64 $235,300 - $283,200	-5,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$47.45 - $58.05 $237,250 - $290,250	5,000 New	5,000 $238,000
Q2 2019 Aug 14, 2019	SELL	$39.26 - $54.21 $1.14 Million - $1.57 Million	-29,045 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$29.84 - $43.92 $866,702 - $1.28 Million	29,045 New	29,045 $1.18 Million

Others Institutions Holding CTLT

# of Institutions

514

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Account

Exodus Point Capital Management, LP Catalent, Inc. Transaction History